HuGE Literature Finder
Records
1
-
27
| IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons???60 years with myelodysplastic syndromes. Experimental hematology & oncology 2022 Oct 11 (1): 73. Wu Junying, Zhang Yudi, Qin Tiejun, Xu Zefeng, Qu Shiqiang, Pan Lijuan, Li Bing, Jia Yujiao, Li Chengwen, Wang Huijun, Gao Qingyan, Cai Wenyu, Gong Jingye, Zhao Songyang, Li Fuhui, Gale Robert Peter, Xiao Zhiji |
| Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management. American journal of hematology 2022 1 97 (3): 352-372. Patnaik Mrinal M, Tefferi Ayal |
| Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromes. Journal of cancer research and clinical oncology 2022 1 148 (4): 845-856. Jiang Lingxu, Ye Li, Ma Liya, Ren Yanling, Zhou Xinping, Mei Chen, Xu Gaixiang, Yang Haiyang, Lu Chenxi, Luo Yingwan, Zhu Shuanghong, Wang Lu, Shen Chuying, Yang Wenli, Zhang Qi, Wang Yuxia, Lang Wei, Han Yueyuan, Jin Jie, Tong Hongy |
| Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes. Cancer medicine 2021 Feb . Yan Xuefen, Wang Lu, Jiang Lingxu, Luo Yingwan, Lin Peipei, Yang Wenli, Ren Yanling, Ma Liya, Zhou Xinping, Mei Chen, Ye Li, Xu Gaixiang, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
| [Correlation between U2AF1 Gene Mutation Characteristics and Clinical Manifestations and Prognosis in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2020 Dec 28 (6): 1977-1984. Zhao Wen-Shu, Zhang Yin-Tian, Jiang Qian-Li, Liu Qi-Fa, Dai M |
| Combining gene variants with clinical characteristics improves outcome prediction in Chinese patients with myelodysplastic syndromes. Leukemia & lymphoma 2019 Dec 1-8. Yu Yan, Zhang Tongtong, Bao Xiebing, Wang Qinrong, Zhang Ling, Hong Yang, Zeng Zhao, Shen Hongjie, Wu Depei, Pan Jinlan, Liu Hong, Chen Suning, Sun Aini |
| Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern. Blood advances 2019 Oct 3 (20): 3111-3122. Berger Gerbrig, Gerritsen Mylene, Yi Guoqiang, Koorenhof-Scheele Theresia N, Kroeze Leonie I, Stevens-Kroef Marian, Yoshida Kenichi, Shiraishi Yuichi, van den Berg Eva, Schepers Hein, Huls Geert, Mulder André B, Ogawa Seishi, Martens Joost H A, Jansen Joop H, Vellenga E |
| [Mutation analysis of 77 patients with normal-karyotype myelodysplastic syndrome]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 Sep 36 (9): 857-861. Qin Wei, Chen Meiyu, Cai Xiaohui, Chao Hongying, Liu Jie, Jiang Naike, Zhou Min, Lu Xuzhang, Chen Suning, Zhang Ri, He Chuan, Wang Qi |
| Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine. Oncotarget 2018 Apr 9 (27): 19342-19355. Cabezón Marta, Bargay Joan, Xicoy Blanca, García Olga, Borrás Josep, Tormo Mar, Marcé Sílvia, Pedro Carme, Valcárcel David, Jiménez Maria-José, Guàrdia Ramón, Palomo Laura, Brunet Salut, Vall-Llovera Ferran, Garcia Antoni, Feliu Evarist, Zamora Lurdes, |
| Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes. Journal of cancer research and clinical oncology 2018 Mar . Lin Peipei, Luo Yingwan, Zhu Shuanghong, Maggio Dominic, Yang Haiyang, Hu Chao, Wang Jinghan, Zhang Hua, Ren Yanling, Zhou Xinping, Mei Chen, Ma Liya, Xu Weilai, Ye Li, Zhuang Zhengping, Jin Jie, Tong Hongy |
| Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing. Oncotarget 2017 Oct 8 (47): 82475-82490. Xu Yuanyuan, Li Yan, Xu Qingyu, Chen Yuelong, Lv Na, Jing Yu, Dou Liping, Bo Jian, Hou Guangyuan, Guo Jing, Wang Xiuli, Wang Lili, Li Yonghui, Chen Chongjian, Yu |
| Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R. American journal of hematology 2017 Sep . Tefferi Ayalew, Lasho Terra L, Patnaik Mrinal M, Saeed Lyla, Mudireddy Mythri, Idossa Dame, Finke Christy, Ketterling Rhett P, Pardanani Animesh, Gangat Nasee |
| Clinical significance of somatic mutation in unexplained blood cytopenia. Blood 2017 Apr . Malcovati Luca, Gallì Anna, Travaglino Erica, Ambaglio Ilaria, Rizzo Ettore, Molteni Elisabetta, Elena Chiara, Ferretti Virginia Valeria, Catricalà Silvia, Bono Elisa, Todisco Gabriele, Bianchessi Antonio, Rumi Elisa, Zibellini Silvia, Pietra Daniela, Boveri Emanuela, Camaschella Clara, Toniolo Daniela, Papaemmanuil Elli, Ogawa Seishi, Cazzola Mar |
| Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome. Oncotarget 2016 Jul . Jung Seung-Hyun, Kim Yoo-Jin, Yim Seon-Hee, Kim Hye-Jung, Kwon Yong-Rim, Hur Eun-Hye, Goo Bon-Kwan, Choi Yun-Suk, Lee Sug Hyung, Chung Yeun-Jun, Lee Je-Hw |
| Clonal hematopoiesis in acquired aplastic anemia. Blood 2016 Apr . Ogawa Seis |
| Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing. American journal of hematology 2016 Feb . Patnaik Mrinal M, Lasho Terra L, Finke Christy M, Hanson Curtis A, King Rebecca L, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal |
| Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes. PloS one 2016 11 (10): e0164370. Abáigar María, Robledo Cristina, Benito Rocío, Ramos Fernando, Díez-Campelo María, Hermosín Lourdes, Sánchez-Del-Real Javier, Alonso Jose M, Cuello Rebeca, Megido Marta, Rodríguez Juan N, Martín-Núñez Guillermo, Aguilar Carlos, Vargas Manuel, Martín Ana A, García Juan L, Kohlmann Alexander, Del Cañizo M Consuelo, Hernández-Rivas Jesús |
| Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell reports 2015 Mar 10 (8): 1239-45. McKerrell Thomas, Park Naomi, Moreno Thaidy, Grove Carolyn S, Ponstingl Hannes, Stephens Jonathan, , Crawley Charles, Craig Jenny, Scott Mike A, Hodkinson Clare, Baxter Joanna, Rad Roland, Forsyth Duncan R, Quail Michael A, Zeggini Eleftheria, Ouwehand Willem, Varela Ignacio, Vassiliou George |
| IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution. American journal of hematology 2014 Feb 89 (2): 137-44. Lin Chien-Chin, Hou Hsin-An, Chou Wen-Chien, Kuo Yuan-Yeh, Liu Chieh-Yu, Chen Chien-Yuan, Lai Yan-Jun, Tseng Mei-Hsuan, Huang Chi-Fei, Chiang Ying-Chieh, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Huang Shang-Yi, Ko Bor-Sheng, Wu Shang-Ju, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa |
| Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 2014 Feb 28 (2): 241-7. Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, Schnittger S, Sanada M, Kon A, Alpermann T, Yoshida K, Roller A, Nadarajah N, Shiraishi Y, Shiozawa Y, Chiba K, Tanaka H, Koeffler H P, Klein H-U, Dugas M, Aburatani H, Kohlmann A, Miyano S, Haferlach C, Kern W, Ogawa |
| Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Leukemia 2014 Jan 28 (1): 78-87. Traina F, Visconte V, Elson P, Tabarroki A, Jankowska A M, Hasrouni E, Sugimoto Y, Szpurka H, Makishima H, O'Keefe C L, Sekeres M A, Advani A S, Kalaycio M, Copelan E A, Saunthararajah Y, Olalla Saad S T, Maciejewski J P, Tiu R |
| Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes. Haematologica 2013 Dec 98 (12): 1856-64. Fernandez-Mercado Marta, Burns Adam, Pellagatti Andrea, Giagounidis Aristoteles, Germing Ulrich, Agirre Xabier, Prosper Felipe, Aul Carlo, Killick Sally, Wainscoat James S, Schuh Anna, Boultwood Jacqueli |
| BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders. Blood 2013 Oct 122 (18): 3169-77. Damm Frederik, Chesnais Virginie, Nagata Yasunobu, Yoshida Kenichi, Scourzic Laurianne, Okuno Yusuke, Itzykson Raphael, Sanada Masashi, Shiraishi Yuichi, Gelsi-Boyer Véronique, Renneville Aline, Miyano Satoru, Mori Hiraku, Shih Lee-Yung, Park Sophie, Dreyfus François, Guerci-Bresler Agnes, Solary Eric, Rose Christian, Cheze Stéphane, Prébet Thomas, Vey Norbert, Legentil Marion, Duffourd Yannis, de Botton Stéphane, Preudhomme Claude, Birnbaum Daniel, Bernard Olivier A, Ogawa Seishi, Fontenay Michaela, Kosmider Olivi |
| Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia. Haematologica 2013 Jan . Shih AH, Chung SS, Dolezal EK, Zhang SJ, Abdel-Wahab OI, Park CY, Nimer SD, Levine RL, Klimek VM |
| Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Sep 30 (27): 3376-82. Bejar Rafael, Stevenson Kristen E, Caughey Bennett A, Abdel-Wahab Omar, Steensma David P, Galili Naomi, Raza Azra, Kantarjian Hagop, Levine Ross L, Neuberg Donna, Garcia-Manero Guillermo, Ebert Benjamin |
| Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 2012 Apr 119 (15): 3578-84. Thol Felicitas, Kade Sofia, Schlarmann Carola, Löffeld Patrick, Morgan Michael, Krauter Jürgen, Wlodarski Marcin W, Kölking Britta, Wichmann Martin, Görlich Kerstin, Göhring Gudrun, Bug Gesine, Ottmann Oliver, Niemeyer Charlotte M, Hofmann Wolf-Karsten, Schlegelberger Brigitte, Ganser Arnold, Heuser Micha |
| Rare occurrence of DNMT3A mutations in myelodysplastic syndromes. Haematologica 2011 Dec 96 (12): 1870-3. Thol Felicitas, Winschel Claudia, Lüdeking Andrea, Yun Haiyang, Friesen Inna, Damm Frederik, Wagner Katharina, Krauter Jürgen, Heuser Michael, Ganser Arno |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: